Strain Measurements During Adenosine Triphosphate Infusion Before and After Percutaneous Coronary Intervention

被引:3
|
作者
Hosaka, Motoko
Takagi, Atsushi [1 ]
Takagi, Tsutomu [2 ]
Ashihara, Kyomi
Hagiwara, Nobuhisa
机构
[1] Tokyo Womens Med Univ, Shinjuku Ku, Tokyo 1628666, Japan
[2] Takagi Cardiol Clin, Kyoto, Japan
关键词
Adenosine; Coronary artery disease; Tissue Doppler imaging; ACUTELY ISCHEMIC-MYOCARDIUM; PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY; VENTRICULAR DELAYED RELAXATION; ARTERY-DISEASE; DOPPLER-ECHOCARDIOGRAPHY; COLOR KINESIS; TISSUE DOPPLER; WALL-MOTION; VELOCITY; ANGIOPLASTY;
D O I
10.1253/circj.CJ-09-0972
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In regional myocardial ischemia, contractile delay develops, which can be assessed by measuring time to peak strain (TPS) on tissue Doppler imaging. The aims of the present study were to clarify the usefulness of TPS measurements during adenosine triphosphate (ATP) stress in assessing myocardial ischemia and to evaluate whether prolongation of TPS disappears immediately after percutaneous coronary intervention (PCI) or not. Methods and Results: A total of 26 patients underwent strain measurements before and after PCI. Corrected TPS for heart rate (TPSc) in target regions and in control regions were measured both at baseline and during ATP infusion. TPSc ratio was calculated as a ratio of TPSc during ATP stress to TPSc at baseline. TPSc in the target region significantly increased during ATP infusion before PCI, which was significantly longer than hyperemic TPSc in control regions. Accordingly, TPSc ratio in the target regions before PCI was significantly greater than that in control regions (1.22 +/- 0.17 vs 0.96 +/- 0.09, respectively, P<0.0001). Following PCI, the TPSc ratio in the target regions significantly decreased to 0.98 +/- 0.05 (P<0.0001). Receiver operating characteristic curve analysis provided a cutoff of 1.04 in TPSc ratio for detecting myocardial ischemia with a sensitivity of 93% and specificity of 93%. Conclusions: TPS measurements during ATP stress differentiated target from control myocardium before PCI. The prolongation of TPSc disappeared immediately after PCI. (Circ J 2010; 74: 1600-1608)
引用
收藏
页码:1600 / 1608
页数:9
相关论文
共 50 条
  • [21] Clopidogrel Before Elective Percutaneous Coronary Intervention
    Motovska, Zuzana
    Widimsky, Petr
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (04): : 373 - 379
  • [22] Platelet Reactivity Measurements Before and After Percutaneous Coronary Intervention Among Patients Undergoing Early Invasive Management for Acute Coronary Syndrome
    Carvalho, Leonardo
    Tang, Chin Chee
    Long, Teo Zhen
    Yan, Bryan
    Huang, Xu-Rui
    Troughton, Richard
    Fong, Alan
    Mejin, Melissa
    Ting, Chloe
    Jing, Mingxue
    Kong, Kylie
    Hang, Ronald Lee Chi
    Chia, Boon Lock
    Tang, Huay Cheem
    Richards, Arthur Mark
    Chan, Mark
    [J]. CIRCULATION, 2013, 128 (22)
  • [23] Thrombocytopenia after abciximab use during percutaneous coronary intervention
    Gribbin, GM
    Thambyrajah, J
    Wright, RA
    Hall, JA
    Harcombe, AA
    De Belder, MA
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 544 - 544
  • [24] OCT sequence registration before and after percutaneous coronary intervention (stent implantation)
    Tsiknakis, Nikos
    Spanakis, Constantinos
    Tsoumpou, Panagiota
    Karanasiou, Georgia
    Karanasiou, Gianna
    Sakellarios, Antonis
    Rigas, George
    Kyriakidis, Savvas
    Papafaklis, Michail I.
    Nikopoulos, Sotirios
    Gijsen, Frank
    Michalis, Lampros
    Fotiadis, Dimitrios I.
    Marias, Kostas
    [J]. BIOMEDICAL SIGNAL PROCESSING AND CONTROL, 2023, 79
  • [25] Plasma levels of osteopontin before and 24 h after percutaneous coronary intervention
    Georgiadou, P.
    Iliodromitis, E. K.
    Kolokathis, F.
    Mavroidis, M.
    Andreadou, I.
    Demopoulou, M.
    Varounis, Ch
    Capetanaki, Y.
    Boudoulas, H.
    Kremastinos, D. Th
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (12) : 1477 - 1480
  • [26] Coronary Circulatory Indexes Before and After Percutaneous Coronary Intervention in a Porcine Tandem Stenoses Model
    Chang, Haseong
    Kim, Hyun Kuk
    Shin, Doosup
    Lim, Kyung Seob
    Kim, Sun-Uk
    Jeon, Chang-Yeop
    Lee, Hwal-Yong
    Lee, Youngjeon
    Won, Jinyoung
    Lee, Seung Hun
    Kakuta, Tsunekazu
    Lee, Joo Myung
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (15):
  • [27] The use of cardiovascular medications in patients with coronary artery disease before and after percutaneous coronary intervention
    Tangsucharit, P.
    Samkaew, T.
    Laowachirasuwan, C.
    Jantaruechai, S.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2014, 10 (05): : E56 - E56
  • [28] Coronary vessel diameters during and after primary percutaneous coronary artery intervention
    Sahin, M.
    Demir, S.
    Kocabay, G.
    Bulut, M.
    Alici, G.
    Ozkan, B.
    Fedakar, A.
    Turkmen, M.
    Boztosun, B.
    [J]. HERZ, 2014, 39 (04) : 515 - 521
  • [29] Postprocedure bivalirudin infusion for primary percutaneous coronary intervention
    Shah, Rahman
    Naz, Arshi
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 94 (06) : 900 - 901
  • [30] Abbreviated Infusion of Eptifibatide After Successful Coronary Intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) Randomized Trial
    Fung, Anthony Y.
    Saw, Jacqueline
    Starovoytov, Andrew
    Densem, Cameron
    Jokhi, Percy
    Walsh, Simon J.
    Fox, Rebecca S.
    Humphries, Karin H.
    Aymong, Eve
    Ricci, Donald R.
    Webb, John G.
    Hamburger, Jaap N.
    Carere, Ronald G.
    Buller, Christopher E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : 837 - 845